Correlation Between Ultragenyx and FibroGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and FibroGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and FibroGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and FibroGen, you can compare the effects of market volatilities on Ultragenyx and FibroGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of FibroGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and FibroGen.

Diversification Opportunities for Ultragenyx and FibroGen

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Ultragenyx and FibroGen is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and FibroGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroGen and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with FibroGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroGen has no effect on the direction of Ultragenyx i.e., Ultragenyx and FibroGen go up and down completely randomly.

Pair Corralation between Ultragenyx and FibroGen

Given the investment horizon of 90 days Ultragenyx is expected to generate 0.27 times more return on investment than FibroGen. However, Ultragenyx is 3.75 times less risky than FibroGen. It trades about -0.07 of its potential returns per unit of risk. FibroGen is currently generating about -0.03 per unit of risk. If you would invest  4,387  in Ultragenyx on December 22, 2024 and sell it today you would lose (469.00) from holding Ultragenyx or give up 10.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ultragenyx  vs.  FibroGen

 Performance 
       Timeline  
Ultragenyx 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
FibroGen 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days FibroGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ultragenyx and FibroGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultragenyx and FibroGen

The main advantage of trading using opposite Ultragenyx and FibroGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, FibroGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will offset losses from the drop in FibroGen's long position.
The idea behind Ultragenyx and FibroGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Transaction History
View history of all your transactions and understand their impact on performance